Free Trial

BioLargo (BLGO) Competitors

BioLargo logo
$0.07 +0.00 (+0.29%)
As of 10:36 AM Eastern

BLGO vs. FSI, NTIC, AVD, BIOX, and LOOP

Should you buy BioLargo stock or one of its competitors? BioLargo's main competitors and comparable companies include Flexible Solutions International (FSI), Northern Technologies International (NTIC), American Vanguard (AVD), Bioceres Crop Solutions (BIOX), and Loop Industries (LOOP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "chemicals" industry.

How does BioLargo compare to Flexible Solutions International?

Flexible Solutions International (NYSE:FSI) and BioLargo (NASDAQ:BLGO) are both small-cap materials companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Flexible Solutions International has a net margin of 10.80% compared to BioLargo's net margin of -11.45%. Flexible Solutions International's return on equity of 10.61% beat BioLargo's return on equity.

Company Net Margins Return on Equity Return on Assets
Flexible Solutions International10.80% 10.61% 7.32%
BioLargo -11.45%-39.90%-22.06%

Flexible Solutions International has a beta of 1.79, suggesting that its stock price is 79% more volatile than the broader market. Comparatively, BioLargo has a beta of -0.05, suggesting that its stock price is 105% less volatile than the broader market.

In the previous week, BioLargo had 1 more articles in the media than Flexible Solutions International. MarketBeat recorded 1 mentions for BioLargo and 0 mentions for Flexible Solutions International. Flexible Solutions International's average media sentiment score of 1.00 beat BioLargo's score of 0.36 indicating that Flexible Solutions International is being referred to more favorably in the media.

Company Overall Sentiment
Flexible Solutions International Positive
BioLargo Neutral

Flexible Solutions International has higher revenue and earnings than BioLargo. Flexible Solutions International is trading at a lower price-to-earnings ratio than BioLargo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Flexible Solutions International$35.58M2.30$2.78M-$0.24N/A
BioLargo$12.23M1.87-$3.50M-$0.05N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Flexible Solutions International
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
3.00
BioLargo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

54.3% of Flexible Solutions International shares are held by institutional investors. Comparatively, 0.0% of BioLargo shares are held by institutional investors. 35.0% of Flexible Solutions International shares are held by company insiders. Comparatively, 19.9% of BioLargo shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Flexible Solutions International beats BioLargo on 13 of the 15 factors compared between the two stocks.

How does BioLargo compare to Northern Technologies International?

BioLargo (NASDAQ:BLGO) and Northern Technologies International (NASDAQ:NTIC) are both small-cap materials companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, earnings, risk, profitability, media sentiment, valuation and institutional ownership.

Northern Technologies International has a net margin of -1.26% compared to BioLargo's net margin of -11.45%. Northern Technologies International's return on equity of -0.45% beat BioLargo's return on equity.

Company Net Margins Return on Equity Return on Assets
BioLargo-11.45% -39.90% -22.06%
Northern Technologies International -1.26%-0.45%-0.33%

0.0% of BioLargo shares are owned by institutional investors. Comparatively, 32.9% of Northern Technologies International shares are owned by institutional investors. 19.9% of BioLargo shares are owned by insiders. Comparatively, 24.9% of Northern Technologies International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioLargo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Northern Technologies International
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

BioLargo has a beta of -0.05, suggesting that its stock price is 105% less volatile than the broader market. Comparatively, Northern Technologies International has a beta of 0.15, suggesting that its stock price is 85% less volatile than the broader market.

Northern Technologies International has higher revenue and earnings than BioLargo. Northern Technologies International is trading at a lower price-to-earnings ratio than BioLargo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioLargo$12.23M1.87-$3.50M-$0.05N/A
Northern Technologies International$84.24M0.87$20K-$0.12N/A

In the previous week, Northern Technologies International had 2 more articles in the media than BioLargo. MarketBeat recorded 3 mentions for Northern Technologies International and 1 mentions for BioLargo. BioLargo's average media sentiment score of 0.36 beat Northern Technologies International's score of 0.21 indicating that BioLargo is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BioLargo
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Northern Technologies International
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Northern Technologies International beats BioLargo on 10 of the 14 factors compared between the two stocks.

How does BioLargo compare to American Vanguard?

BioLargo (NASDAQ:BLGO) and American Vanguard (NYSE:AVD) are both small-cap materials companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership.

BioLargo has a net margin of -11.45% compared to American Vanguard's net margin of -11.99%. American Vanguard's return on equity of -16.57% beat BioLargo's return on equity.

Company Net Margins Return on Equity Return on Assets
BioLargo-11.45% -39.90% -22.06%
American Vanguard -11.99%-16.57%-4.70%

0.0% of BioLargo shares are owned by institutional investors. Comparatively, 79.0% of American Vanguard shares are owned by institutional investors. 19.9% of BioLargo shares are owned by insiders. Comparatively, 5.6% of American Vanguard shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioLargo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
American Vanguard
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, American Vanguard had 9 more articles in the media than BioLargo. MarketBeat recorded 10 mentions for American Vanguard and 1 mentions for BioLargo. BioLargo's average media sentiment score of 0.36 beat American Vanguard's score of -0.31 indicating that BioLargo is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BioLargo
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
American Vanguard
0 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

BioLargo has higher earnings, but lower revenue than American Vanguard. BioLargo is trading at a lower price-to-earnings ratio than American Vanguard, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioLargo$12.23M1.87-$3.50M-$0.05N/A
American Vanguard$515.11M0.05-$49.88M-$2.08N/A

BioLargo has a beta of -0.05, meaning that its share price is 105% less volatile than the broader market. Comparatively, American Vanguard has a beta of 1.56, meaning that its share price is 56% more volatile than the broader market.

Summary

American Vanguard beats BioLargo on 8 of the 14 factors compared between the two stocks.

How does BioLargo compare to Bioceres Crop Solutions?

Bioceres Crop Solutions (NASDAQ:BIOX) and BioLargo (NASDAQ:BLGO) are both small-cap materials companies, but which is the better business? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

17.7% of Bioceres Crop Solutions shares are owned by institutional investors. Comparatively, 0.0% of BioLargo shares are owned by institutional investors. 2.3% of Bioceres Crop Solutions shares are owned by insiders. Comparatively, 19.9% of BioLargo shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Bioceres Crop Solutions currently has a consensus target price of $2.00, suggesting a potential upside of 800.90%. Given Bioceres Crop Solutions' stronger consensus rating and higher possible upside, research analysts clearly believe Bioceres Crop Solutions is more favorable than BioLargo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bioceres Crop Solutions
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
BioLargo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

BioLargo has lower revenue, but higher earnings than Bioceres Crop Solutions. BioLargo is trading at a lower price-to-earnings ratio than Bioceres Crop Solutions, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bioceres Crop Solutions$238.30M0.06-$258.15M-$3.66N/A
BioLargo$12.23M1.87-$3.50M-$0.05N/A

BioLargo has a net margin of -11.45% compared to Bioceres Crop Solutions' net margin of -105.94%. BioLargo's return on equity of -39.90% beat Bioceres Crop Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
Bioceres Crop Solutions-105.94% -72.02% -11.07%
BioLargo -11.45%-39.90%-22.06%

Bioceres Crop Solutions has a beta of 0.54, indicating that its stock price is 46% less volatile than the broader market. Comparatively, BioLargo has a beta of -0.05, indicating that its stock price is 105% less volatile than the broader market.

In the previous week, Bioceres Crop Solutions had 4 more articles in the media than BioLargo. MarketBeat recorded 5 mentions for Bioceres Crop Solutions and 1 mentions for BioLargo. BioLargo's average media sentiment score of 0.36 beat Bioceres Crop Solutions' score of 0.03 indicating that BioLargo is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bioceres Crop Solutions
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BioLargo
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Bioceres Crop Solutions and BioLargo tied by winning 7 of the 14 factors compared between the two stocks.

How does BioLargo compare to Loop Industries?

BioLargo (NASDAQ:BLGO) and Loop Industries (NASDAQ:LOOP) are both small-cap materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

In the previous week, BioLargo and BioLargo both had 1 articles in the media. Loop Industries' average media sentiment score of 0.91 beat BioLargo's score of 0.36 indicating that Loop Industries is being referred to more favorably in the news media.

Company Overall Sentiment
BioLargo Neutral
Loop Industries Positive

BioLargo has higher revenue and earnings than Loop Industries. BioLargo is trading at a lower price-to-earnings ratio than Loop Industries, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioLargo$12.23M1.87-$3.50M-$0.05N/A
Loop Industries$510K20.15-$12.30M-$0.25N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioLargo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Loop Industries
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

0.0% of BioLargo shares are held by institutional investors. Comparatively, 4.9% of Loop Industries shares are held by institutional investors. 19.9% of BioLargo shares are held by insiders. Comparatively, 49.7% of Loop Industries shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

BioLargo has a beta of -0.05, meaning that its stock price is 105% less volatile than the broader market. Comparatively, Loop Industries has a beta of 1.54, meaning that its stock price is 54% more volatile than the broader market.

BioLargo has a net margin of -11.45% compared to Loop Industries' net margin of -2,154.12%. Loop Industries' return on equity of 0.00% beat BioLargo's return on equity.

Company Net Margins Return on Equity Return on Assets
BioLargo-11.45% -39.90% -22.06%
Loop Industries -2,154.12%N/A -146.03%

Summary

Loop Industries beats BioLargo on 7 of the 12 factors compared between the two stocks.

Get BioLargo News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLGO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLGO vs. The Competition

MetricBioLargoChemicals IndustryMaterials SectorNASDAQ Exchange
Market Cap$22.88M$11.43B$4.61B$12.01B
Dividend YieldN/A2.97%4.30%4.50%
P/E Ratio-6.8033.8827.9430.36
Price / Sales1.872.415.755.82
Price / CashN/A14.8120.8922.80
Price / Book6.803.424.073.77
Net Income-$3.50M$235.78M$159.56M$390.55M
7 Day PerformanceN/A-0.11%-1.57%-0.58%
1 Month PerformanceN/A-1.44%-6.44%-6.84%
1 Year PerformanceN/A11.16%7.69%-6.12%

BioLargo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLGO
BioLargo
N/A$0.07
+0.3%
N/A-59.9%$22.88M$12.23MN/A30
FSI
Flexible Solutions International
2.7273 of 5 stars
$6.14
-2.1%
N/A-20.2%$78.43M$35.58M18.6178
NTIC
Northern Technologies International
1.8581 of 5 stars
$7.58
-1.8%
N/A-4.8%$72.01M$84.24MN/A94
AVD
American Vanguard
0.9644 of 5 stars
$0.95
-2.6%
N/A-82.0%$28.05M$515.11MN/A739
BIOX
Bioceres Crop Solutions
2.519 of 5 stars
$0.21
-16.1%
$2.00
+841.2%
-88.1%$13.56M$237.80MN/A751

Related Companies and Tools


This page (NASDAQ:BLGO) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners